Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -48.39% is 34% below its 5-year average of -36.13%, near the low end of its 5-year range (-51.46%–-16.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.63% above its 12-month average of -48.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -48.39%.
RETURN ON INVESTED CAPITAL (ROIC)
-48.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-48.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-36.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.63%
CURRENT VS 3Y AVG
-13.12%
CURRENT VS 5Y AVG
-33.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.19%
median of 714 covered companies
CURRENT VS SECTOR MEDIAN
-45.81%
vs the sector median at left
Pulmonx Corporation
Market Cap
$77.93M
Return on Invested Capital (ROIC)
-48.39%
TTM Avg
-48.69%
3Y Avg
-42.77%
5Y Avg
-36.13%
Market Cap
$78.31M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.46M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$76.10M
Return on Invested Capital (ROIC)
-33.27%
TTM Avg
-39.30%
3Y Avg
-47.63%
5Y Avg
-42.37%
Market Cap
$75.84M
Return on Invested Capital (ROIC)
-62.98%
TTM Avg
-85.67%
3Y Avg
-71.66%
5Y Avg
-59.37%
Market Cap
$80.96M
Return on Invested Capital (ROIC)
-59.79%
TTM Avg
-61.79%
3Y Avg
-56.24%
5Y Avg
-67.61%
Market Cap
$81.81M
Return on Invested Capital (ROIC)
-126.99%
TTM Avg
-110.63%
3Y Avg
-85.52%
5Y Avg
-67.36%
Market Cap
$82.39M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$82.45M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $77.93M | -48.39% | -48.69% | -42.77% | -36.13% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -836.58% | -213.85% | -158.30% | -121.35% |
| Outset Medical, Inc. (OM)vs › | $76.10M | -33.27% | -39.30% | -47.63% | -42.37% |
| Hyperfine, Inc. (HYPR)vs › | $75.84M | -62.98% | -85.67% | -71.66% | -59.37% |
| Sera Prognostics, Inc. (SERA)vs › | $80.96M | -59.79% | -61.79% | -56.24% | -67.61% |
| Nutriband Inc. (NTRB)vs › | $81.81M | -126.99% | -110.63% | -85.52% | -67.36% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.39M | -88.28% | -61.59% | -48.92% | -67.61% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -31.62% | -27.86% | -23.01% | -20.58% |
| LENSAR Inc (LNSR)vs › | $82.90M | -16.28% | -50.22% | -41.74% | -37.86% |
ROIC
-48.4%
ROE
-122.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -48.39% |
| 2026-03-31 | -51.46% |
| 2025-12-31 | -48.54% |
| 2025-09-30 | -49.50% |
| 2025-06-30 | -45.59% |
| 2025-03-31 | -43.21% |
| 2024-12-31 | -40.75% |
| 2024-09-30 | -38.84% |
| 2024-06-30 | -37.88% |
| 2024-03-31 | -40.45% |
| 2023-12-31 | -39.50% |
| 2023-09-30 | -37.27% |
| 2023-06-30 | -34.68% |
| 2023-03-31 | -31.65% |
| 2022-12-31 | -32.77% |
| 2022-09-30 | -29.88% |
| 2022-06-30 | -26.33% |
| 2022-03-31 | -24.16% |
| 2021-12-31 | -21.73% |
| 2021-09-30 | -19.27% |
| 2021-06-30 | -16.88% |
| 2021-03-31 | -15.90% |
| 2020-12-31 | -12.76% |
| 2020-09-30 | -47.02% |
| 2020-06-30 | -43.18% |
| 2019-12-31 | -44.52% |
